|
| 38051788 | The immunogenicity of an HIV-1 Gag conserved element DNA vaccine in people with HIV and receiving antiretroviral therapy. | AIDS | 2024 |
| 35975297 | Cytomegalovirus Immunoglobulin G (IgG) Titer and Coronary Artery Disease in People With Human Immunodeficiency Virus (HIV). | Clin Infect Dis | 2023 |
| 37663091 | The Penn Medicine COVID-19 Therapeutics Committee-Reflections on a Model for Rapid Evidence Review and Dynamic Practice Recommendations During a Public Health Emergency. | Open Forum Infect Dis | 2023 |
| 37837376 | Participant experiences in HIV cure-directed trial with an extended analytical treatment interruption in Philadelphia, United States. | HIV Res Clin Pract | 2023 |
| 37070542 | Susceptibility to 3BNC117 and 10-1074 in ART suppressed chronically infected persons. | AIDS | 2023 |
| 37463049 | The latent reservoir of inducible, infectious HIV-1 does not decrease despite decades of antiretroviral therapy. | J Clin Invest | 2023 |
| 36727840 | A prospective 18 F-fluorodeoxyglucose positron emission tomography/computed tomography study of the neurometabolic effects in cocaine use and HIV infection. | AIDS | 2023 |
| 35979886 | "I Know That I Was a Part of Making a Difference": Participant Motivations for Joining a Cure-Directed HIV Trial with an Analytical Treatment Interruption. | AIDS Res Hum Retroviruses | 2023 |
| 34409989 | Deconstructing the Treatment Effect of Remdesivir in the Adaptive Coronavirus Disease 2019 (COVID-19) Treatment Trial-1: Implications for Critical Care Resource Utilization. | Clin Infect Dis | 2022 |
| 35348047 | "We are looking at the future right now": community acceptability of a home-based viral load test device in the context of HIV cure-related research with analytical treatment interruptions in the United States. | HIV Res Clin Pract | 2022 |
| 35730977 | Inhibition of a Chromatin and Transcription Modulator, SLTM, Increases HIV-1 Reactivation Identified by a CRISPR Inhibition Screen. | J Virol | 2022 |
| 35536669 | A phase I trial of cyclosporine for hospitalized patients with COVID-19. | JCI Insight | 2022 |
| 35818363 | Unraveling the Treatment Effect of Baricitinib on Clinical Progression and Resource Utilization in Hospitalized COVID-19 Patients: Secondary Analysis of the Adaptive COVID-19 Treatment Randomized Trial-2. | Open Forum Infect Dis | 2022 |
| 36442063 | Temporal Improvements in COVID-19 Outcomes for Hospitalized Adults: A Post Hoc Observational Study of Remdesivir Group Participants in the Adaptive COVID-19 Treatment Trial. | Ann Intern Med | 2022 |
| 35968737 | Participant experiences using novel home-based blood collection device for viral load testing in HIV cure trials with analytical treatment interruptions | HIV Res Clin Pract | 2022 |
| 36202799 | DNA-delivered antibody cocktail exhibits improved pharmacokinetics and confers prophylactic protection against SARS-CoV-2. | Nat Commun | 2022 |
| 35953331 | Debulking different Corona (SARS-CoV-2 delta, omicron, OC43) and Influenza (H1N1, H3N2) virus strains by plant viral trap proteins in chewing gums to decrease infection and transmission. | Biomaterials | 2022 |
| 36351430 | Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. | Cell Rep Med | 2022 |
| 35320704 | Single-cell multiomics reveals persistence of HIV-1 in expanded cytotoxic TÂ cell clones. | Immunity | 2022 |
| 35207719 | Preliminary Acceptability of a Home-Based Peripheral Blood Collection Device for Viral Load Testing in the Context of Analytical Treatment Interruptions in HIV Cure Trials: Results from a Nationwide Survey in the United States. | J Pers Med | 2022 |
| 35026142 | A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial. | Lancet Gastroenterol Hepatol | 2022 |
| 35079784 | SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial. | J Infect Dis | 2022 |
| 35076699 | Association of Convalescent Plasma Treatment With Clinical Status in Patients Hospitalized With COVID-19: A Meta-analysis. | JAMA Netw Open | 2022 |
| 33323024 | Safety, Immune, and Antiviral Effects of Pegylated Interferon Alpha 2b Administration in Antiretroviral Therapy-Suppressed Individuals: Results of Pilot Clinical Trial. | AIDS Res Hum Retroviruses | 2021 |
| 33571163 | CCR5-edited CD4+ T cells augment HIV-specific immunity to enable post-rebound control of HIV replication. | J Clin Invest | 2021 |
| 33527127 | Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy. | Clin Infect Dis | 2021 |
| 34525286 | Safety and Immunogenicity of an Anti-Zika Virus DNA Vaccine. | N Engl J Med | 2021 |
| 34788233 | A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia. | J Clin Invest | 2021 |
| 34543092 | The Natural Stilbenoid (-)-Hopeaphenol Inhibits Cellular Entry of SARS-CoV-2 USA-WA1/2020, B.1.1.7, and B.1.351 Variants. | Antimicrob Agents Chemother | 2021 |
| 34447895 | Lack of Atorvastatin Effect on Monocyte Gene Expression and Inflammatory Markers in HIV-1-infected ART-suppressed Individuals at Risk of non-AIDS Comorbidities. | Pathog Immun | 2021 |
| 34650089 | INO-4800 DNA vaccine induces neutralizing antibodies and T cell activity against global SARS-CoV-2 variants. | NPJ Vaccines | 2021 |
| 34188039 | Non-invasive plasma glycomic and metabolic biomarkers of post-treatment control of HIV. | Nat Commun | 2021 |
| 34127579 | Frequency of post treatment control varies by antiretroviral therapy restart and viral load criteria. | AIDS | 2021 |
| 34086344 | Identification of the predominant human NK cell effector subset mediating ADCC against HIV-infected targets coated with BNAbs or plasma from PLWH. | Eur J Immunol | 2021 |
| 34049356 | Comparable HIV suppression by pegylated-IFN-α2a or pegylated-IFN-α2b during a 4-week analytical treatment interruption. | AIDS | 2021 |
| 33392485 | Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial. | EClinicalMedicine | 2021 |
| 32895573 | Recommendations for measuring HIV reservoir size in cure-directed clinical trials. | Nat Med | 2020 |
| 33166284 | Investigating hospital Mycobacterium chelonae infection using whole genome sequencing and hybrid assembly. | PLoS One | 2020 |
| 33239444 | Autologous IgG antibodies block outgrowth of a substantial but variable fraction of viruses in the latent reservoir for HIV-1. | Proc Natl Acad Sci U S A | 2020 |
| 33119599 | A novel synthetic DNA vaccine elicits protective immune responses against Powassan virus. | PLoS Negl Trop Dis | 2020 |
| 32827942 | Interferon-α alters host glycosylation machinery during treated HIV infection. | EBioMedicine | 2020 |
| 32855181 | SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients. | J Clin Microbiol | 2020 |
| 30730897 | Protective immunity by an engineered DNA vaccine for Mayaro virus. | PLoS Negl Trop Dis | 2019 |
| 31893252 | Evidence for Persistent Monocyte and Immune Dysregulation After Prolonged Viral Suppression Despite Normalization of Monocyte Subsets, sCD14 and sCD163 in HIV-Infected Individuals. | Pathog Immun | 2019 |
| 31253727 | NK Response Correlates with HIV Decrease in Pegylated IFN-α2a-Treated Antiretroviral Therapy-Suppressed Subjects. | J Immunol | 2019 |
| 31335587 | Brief Report: No Evidence for an Association Between Statin Use and Lower Biomarkers of HIV Persistence or Immune Activation/Inflammation During Effective ART. | J Acquir Immune Defic Syndr | 2019 |
| 30891607 | Intradermal SynCon® Ebola GP DNA Vaccine Is Temperature Stable and Safely Demonstrates Cellular and Humoral Immunogenicity Advantages in Healthy Volunteers. | J Infect Dis | 2019 |
| 30885693 | Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meeting. | Lancet HIV | 2019 |
| 28923757 | Clinical Practice and Infrastructure Review of Fecal Microbiota Transplantation for Clostridium difficile Infection. | Chest | 2018 |
| 29911997 | HIV-1 latent reservoir size and diversity are stable following brief treatment interruption. | J Clin Invest | 2018 |